Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
12.8M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.48M
-
Shares change
-
-329K
-
Total reported value, excl. options
-
$1.18M
-
Value change
-
-$289K
-
Number of buys
-
6
-
Number of sells
-
-10
-
Price
-
$0.80
Significant Holders of Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) as of Q1 2025
17 filings reported holding BFRI - Biofrontera Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Biofrontera Inc. - Common Stock, par value $0.001 per share (BFRI) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.48M shares
of 12.8M outstanding shares and own 11.59% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (732K shares), Rosalind Advisors, Inc. (644K shares), GEODE CAPITAL MANAGEMENT, LLC (40.1K shares), CITADEL ADVISORS LLC (28.2K shares), Virtu Financial LLC (18.5K shares), TWO SIGMA SECURITIES, LLC (11.3K shares), BlackRock, Inc. (4.62K shares), SBI Securities Co., Ltd. (309 shares), JPMORGAN CHASE & CO (197 shares), and MORGAN STANLEY (160 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.